Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR-R -0.63%90 3-Year Book Growth Rate is 5.10% as of Jun. 2026, which is 60% below its 10-year median of 12.80. GuruFocus rates BKK:SKR-R with a GF Score™ of 90/100 and a GF Value™ of ฿8.11 (Fairly Valued). The stock has 5 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Sikarin PCL ranks worse than 51.55% on this metric.
During the past 12 months, Sikarin PCL's average Book Value per Share Growth Rate was 0.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 5.10% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 13.00% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 11.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Sikarin PCL was 34.70% per year. The lowest was -3.20% per year. And the median was 12.80% per year.
Sikarin PCL (BKK:SKR-R) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Sikarin PCL 3-Year Book Growth Rate Related Terms
BKK:SKR-R vs HCA, THC, DVA: 3-Year Book Growth Rate Comparison
For the Medical Care Facilities subindustry, Sikarin PCL's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 5.10% mean?
Sikarin PCL (BKK:SKR-R) has a 3-Year Book Growth Rate of 5.10% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Sikarin PCL and its competitors. This is 60% below median its historical median of 12.80. According to the industry distribution chart, Sikarin PCL ranks #300 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 51.5%.
Is Sikarin PCL's 3-Year Book Growth Rate too high?
Sikarin PCL's current 3-Year Book Growth Rate of 5.10% is 60% below median its 10-year median of 12.80. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.50. Sikarin PCL's value of 5.10% is 7.3% below this industry median. Based on the distribution chart, Sikarin PCL ranks #300 out of 582 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sikarin PCL has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's 3-Year Book Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #300 out of 582 companies for 3-Year Book Growth Rate. This places Sikarin PCL in the lower half of its industry. The industry median 3-Year Book Growth Rate is 5.50. Sikarin PCL's value of 5.10% is 7.3% below this benchmark. While the company's 10-year median is 12.80 vs. the industry median of 5.50, Sikarin PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.50, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current 3-Year Book Growth Rate of 5.10% is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current 3-Year Book Growth Rate is 5.10%, which is 60% below median its own 10-year median of 12.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿8.11, compared to a current price of ฿7.85 — trading 3.2% below its estimated fair value. The current 3-Year Book Growth Rate is 5.10%, which is 60% below median its 10-year median of 12.80 and 7.3% below the Healthcare Providers & Services industry median of 5.50. Sikarin PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR-R), the current 3-Year Book Growth Rate is 5.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR-R) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.85 is trading 3.2% below its estimated GF Value™ of ฿8.11.
GuruFocus considers Sikarin PCL to be Fairly Valued.
Key valuation signals for BKK:SKR-R:
3-Year Book Growth Rate: 5.10% (60% below median its 10-year median of 12.80)
GF Value™: ฿8.11 vs. price of ฿7.85 (3.2% below fair value)
Industry Position: 7.3% below the Healthcare Providers & Services median (#300 of 582)
No single metric tells the full story. See the BKK:SKR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
90GF Score
Get the complete analysis for BKK:SKR-R
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR-R has been successfully added to your 
